Cultivated meat accounts for at least 1% of global retail meat sales volume by 2031.

Question

Six frontier AI models put this at 3% by 22 Sept 2031. Full reasoning from every model.

WillHappen.ai · Accepted Answer

3% — the median of 6 frontier models, resolving by 2031-09-22.

Answer

Gemini (Google): 2% — Hitting 1% requires producing over 3 million metric tons annually by 2031, far exceeding global bioreactor buildout capacity. Global meat retail exceeds 350M tons, meaning 1% requires bioreactor capacity hundreds of times larger than total pharma capacity. Capital expenditure for such manufacturing runs into hundreds of billions, which venture markets have severely cut back on. China or the US would need to subsidize megaton-scale facilities immediately, but state bans and high costs stifle growth.

Answer

Claude (Anthropic): 2% — Bioreactor cost curves and regulatory approvals would need to move far faster than any current trajectory suggests. Current global cultivated meat volumes are minuscule (sold in grams/kg in a handful of markets like Singapore and US), nowhere near 1% of hundreds of millions of tons of… Scaling to 1% of global retail volume requires industrial-scale bioreactors, cost parity with conventional meat, and broad regulatory approval across major markets like… Only development that would meaningfully raise odds is a major cost breakthrough (media costs, bioreactor efficiency) plus fast-tracked approvals in China/EU, none…

Answer

GPT (OpenAI): 4% — Reaching 1% needs commodity-scale output and price parity, neither of which current approvals or plants support. By 2031, producers must build and operate many millions of tonnes of capacity, far beyond today’s pilot-scale facilities. Singapore, the US and Israel have approvals, but no cultivated-meat category has yet demonstrated mass-market volume or cost parity. I would raise this sharply if a major producer secured financing and offtake for a >100,000-tonne annual facility by 2028.

Answer

Grok (xAI): 7% — Turns on 1000x+ bioreactor scale-up and cost parity in five years despite tiny current output. Firms need EU/China approvals plus gigafactories online by ~2029; today’s output is tens of tons versus millions required for 1%. Plant-based hit ~1% US share only after a decade of easier tech; cultivated still faces 10-100x costs and stigma. A serum-free media leap or state-backed China buildout would be the clearest upward revision.

Answer

DeepSeek (DeepSeek): 3% — Cultivated meat needs a ~100x scale-up in five years while cost, regulation, and consumer demand all stall. Upside Foods and Good Meat hold US clearances but still sell nothing at retail; Aleph Farms' Israel approval is tiny and pricey. Global meat volume is ~350M tonnes, so 1% means ~3.5M tonnes; current output is thousands of tonnes at best. Singapore's 2020 approval and subsequent retreats show the base rate for food-tech scale-up in five years is near zero.

Answer

Qwen (Alibaba): 2% — Cultivated meat must scale from near-zero to ~3.5M tonnes in five years; no bioreactor capacity or cost trajectory supports that. Global meat production is ~350M tonnes; 1% means ~3.5M tonnes of cultivated output—current global capacity is in the low thousands of tonnes. Even Singapore and Israel, the most permissive regulators, have only a handful of approved products; US, EU, and China approvals remain limited or pending. Cost per kg has fallen but remains 5-10x above conventional meat at any commercial scale; no announced facility approaches the throughput needed for 1% share.

Cultivated meat accounts for at least 1% of global retail meat sales volume by 2031.

Food Standards Australia New Zealand approves cultivated meat for retail sale before 2028.

Cultivated meat products are stocked on shelves in major US national supermarket chains before 2028.

The United Kingdom approves cultivated meat for general retail sale before 2028.

Cultivated meat receives regulatory approval for commercial retail sale in the European Union before 2028.